Review article: Management of peptic ulcer bleeding - The roles of proton pump inhibitors and Helicobacter pylori eradication

Alimentary Pharmacology and Therapeutics, Supplement

Volumn 19, Issue 1, 2004, Pages 66-70

  Holtmann, G ^a   Howden, C W ^b  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; OCTREOTIDE; OMEPRAZOLE; PROTON PUMP INHIBITOR; SOMATOSTATIN;

ACID SECRETION; BACTERIAL INFECTION; CLINICAL TRIAL; DISEASE CONTROL; ELECTROCOAGULATION; ENDOSCOPIC SURGERY; ENDOSCOPY; HELICOBACTER PYLORI; HUMAN; INFECTION CONTROL; MORBIDITY; MORTALITY; PEPTIC ULCER BLEEDING; PRIORITY JOURNAL; RECURRENT DISEASE; REOPERATION; REVIEW; RISK FACTOR;

ANTI-ULCER AGENTS; ENDOSCOPY, GASTROINTESTINAL; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PEPTIC ULCER; PEPTIC ULCER HEMORRHAGE; PROTON PUMPS; RANDOMIZED CONTROLLED TRIALS; RECURRENCE;

EID: 1342289058     PISSN: 09530673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Higham J, Kang J-Y, Majeed A. Recent trends in admission and mortality due to peptic ulcer in England: Increased frequency of hemorrhage among older subjects. Gut 2002; 50: 460-4.
2. Laine LA. Management of ulcers with adherent clots. Gastroenterology 2002; 123: 632-6.
3. Laine L, Peterson WL. Bleeding peptic ulcer. N Engl J Med 1994; 331: 717-27.
4. Jensen DM, Kovacs TOG, Jutabha R, et al. Randomized trial of medical or endoscopic therapy to prevent recurrent ulcer hemorrhage in patients with adherent clots. Gastroenterology 2002; 123: 407-13.
5. Cook DJ. Endoscopic therapy for acute nonvariceal upper gastrointestinal hemorrhage: a meta-analysis. Gastroenterology 1992; 102: 139-48.
6. Marmo R, Rotondano G, Bianco MA, et al. Outcome of endoscopic treatment for peptic ulcer bleeding: Is a second look necessary? A meta-analysis. Gastrointest Endosc 2003; 57: 62-7.
7. Gisbert JP, Gonzalez X, Calvet M, et al. Proton pump inhibitors versus H2-antagonists: a meta-analysis of the efficacy in treating bleeding peptic ulcer. Aliment Pharmacol Ther 2001; 15: 917-27.
8. Khuroo MS, Yattoo GN, Javid G, et al. A comparison of omeprazole and placebo for bleeding peptic ulcer. N Engl J Med 1997; 336: 1054-8.
9. Lau JYW, Sung JJY, Lee KKC, et al. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N Engl J Med 2000; 343: 310-6.
10. Bardou M, Toubouti YM, Benhaberou-Brun D, et al. High dose intravenous proton pump inhibition decrease both re-bleeding and mortality in high-risk patients with acute peptic ulcer bleeding: a series of meta-analyses. Gastroenterology 2003; 124: A-625(Abstract W1079).
11. Barkun AN, Adam V, Kennedy W, Fallone CA, Herba K, Bardou M. The cost-effectiveness of high dose oral versus intravenous proton pump inhibition in high-risk patients with bleeding peptic ulcers having undergone therapeutic endoscopy. Gastroenterology 2003; 124(4): A627(Abstract M1805).
12. Sharma VK, Sahai AV, Corder FA, Howden CW. Helicobacter pylori eradication is superior to ulcer healing with or without maintenance therapy to prevent further ulcer haemorrhage. Aliment Pharmacol Ther 2001; 15: 1939-17.
13. Grino P, Pascual S, Such J, et al. Comparison of diagnostic methods for Helicobacter pylori infection in patients with upper gastrointestinal bleeding. Scand J Gastroenterol 2001; 36: 1254-8.
14. Wildner-Christensen M, Touborg Lassen A, Lindebjerg J, Schaffalitzky de Muchadell OB. Diagnosis of Helicobacter pylori in bleeding peptic ulcer patients, evaluation of urea-based tests. Digestion 2002; 66: 9-13.
15. Lin H-J, Tseng G-Y, Hsieh Y-H, et al. Will Helicobacter pylori affect short-term re-bleeding in peptic ulcer bleeding patients after successful endoscopic therapy? Am J Gastroenterol 1999; 94: 3184-8.
16. Kimmey MB, Lanas A. Review article: appropriate use of proton pump inhibitors with traditional nonsteroidal anti-inflammatory drugs and COX-2 selective inhibitors. Aliment Pharmacol Ther 2004; 19(Suppl. 1): 60-5.
17. Fendrick AM, Garabedian-Ruffalo SM. A clinician's guide to the selection of NSAID therapy. Pharm Ther 2002; 27: 579-82.
18. Lai KC, Lam SK, Chum KM, et al. Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use. N Engl J Med 2002; 346: 2033-8.